Ahmad Ateeq, Wang Yue-Fen, Ahmad Imran
NeoPharm, Inc., Research and Development, Waukegan, IL 60085, USA.
Methods Enzymol. 2005;391:176-85. doi: 10.1016/S0076-6879(05)91010-0.
A method is described for quantification of the liposomal and nonliposomal forms of mitoxantrone (MTO) in mouse plasma after intravenous administration of liposome-entrapped MTO Easy-to-Use (LEM-ETU) formulation. This is based on the property of liposome-entrapped MTO (LEM) to pass through reversed-phase C(18) silica gel cartridges, while nonliposomal MTO or free MTO is retained with strong hydrophobicity and later is eluted with acidic methanol. Extraction of LEM and free MTO from plasma is performed in two steps. This technique is rapid and sensitive and can be used for a large series of sample preparation. The plasma samples are found stable after one freeze-thaw cycle. The recovery of MTO, as well as the precision, linearity, and accuracy of the method for both free and liposomal MTO, appears satisfactory for pharmacokinetic studies. The pharmacokinetic results in mice show a sustained release of MTO from LEM-ETU.
描述了一种在静脉注射脂质体包裹的米托蒽醌易使用(LEM-ETU)制剂后,对小鼠血浆中脂质体形式和非脂质体形式的米托蒽醌(MTO)进行定量的方法。这基于脂质体包裹的MTO(LEM)能够通过反相C(18)硅胶柱的特性,而非脂质体MTO或游离MTO则因强疏水性而被保留,随后用酸性甲醇洗脱。从血浆中提取LEM和游离MTO分两步进行。该技术快速且灵敏,可用于大量样品的制备。血浆样品在一次冻融循环后保持稳定。对于药代动力学研究而言,MTO的回收率以及该方法对游离和脂质体MTO的精密度、线性和准确度似乎都令人满意。小鼠的药代动力学结果表明,MTO从LEM-ETU中持续释放。